Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior
Patrick A. Randall, Kiran Vemuri, Kristen N. Segovia, et al.
Pharmacology Biochemistry and Behavior (2010) Vol. 97, Iss. 1, pp. 179-184
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Anti-obesity drugs: past, present and future
R.J. Rodgers, Matthias H. Tschöp, John Wilding
Disease Models & Mechanisms (2012) Vol. 5, Iss. 5, pp. 621-626
Open Access | Times Cited: 418
Pharmacotherapy of obesity: Available medications and drugs under investigation
Eleni Pilitsi, Olivia M. Farr, Stergios A. Pοlyzos, et al.
Metabolism (2018) Vol. 92, pp. 170-192
Open Access | Times Cited: 228
Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon
Gitanjali Srivastava, Caroline M. Apovian
Current Obesity Reports (2018) Vol. 7, Iss. 2, pp. 147-161
Closed Access | Times Cited: 211
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 83
Regulation of nausea and vomiting by cannabinoids
Linda A. Parker, Erin M. Rock, Cheryl L. Limebeer
British Journal of Pharmacology (2010) Vol. 163, Iss. 7, pp. 1411-1422
Open Access | Times Cited: 243
A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents
NL Cluny, VK Vemuri, AP Chambers, et al.
British Journal of Pharmacology (2010) Vol. 161, Iss. 3, pp. 629-642
Open Access | Times Cited: 187
Dopaminergic Modulation of Effort-Related Choice Behavior as Assessed by a Progressive Ratio Chow Feeding Choice Task: Pharmacological Studies and the Role of Individual Differences
Patrick A. Randall, Marta Pardo, Eric J. Nunes, et al.
PLoS ONE (2012) Vol. 7, Iss. 10, pp. e47934-e47934
Open Access | Times Cited: 186
Endocannabinoids in the Gut
Nicholas V. DiPatrizio
Cannabis and Cannabinoid Research (2016) Vol. 1, Iss. 1, pp. 67-77
Open Access | Times Cited: 128
The therapeutic potential of second and third generation CB1R antagonists
Reşat Çınar, Malliga R. Iyer, George Kunos
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107477-107477
Open Access | Times Cited: 109
Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity
Donovan A. Argueta, Nicholas V. DiPatrizio
Physiology & Behavior (2017) Vol. 171, pp. 32-39
Open Access | Times Cited: 106
Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development
Thuy Nguyen, Brian F. Thomas, Yanan Zhang
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 16, pp. 1418-1435
Open Access | Times Cited: 85
Energy balance regulation by endocannabinoids at central and peripheral levels
Carmelo Quarta, Roberta Mazza, Silvana Obici, et al.
Trends in Molecular Medicine (2011) Vol. 17, Iss. 9, pp. 518-526
Closed Access | Times Cited: 90
Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders
Cristoforo Silvestri, Vincenzo Di Marzo
Expert Opinion on Investigational Drugs (2012) Vol. 21, Iss. 9, pp. 1309-1322
Closed Access | Times Cited: 76
Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases
João Victor da Silva Guerra, Marieli M. G. Dias, Anna Julyana Viana Chianca Brilhante, et al.
Nutrients (2021) Vol. 13, Iss. 8, pp. 2830-2830
Open Access | Times Cited: 48
Endocannabinoids and the Gut-Brain Control of Food Intake and Obesity
Nicholas V. DiPatrizio
Nutrients (2021) Vol. 13, Iss. 4, pp. 1214-1214
Open Access | Times Cited: 42
Regulation of Brain Reward by the Endocannabinoid System: A Critical Review of Behavioral Studies in Animals
Styliani Vlachou, George Panagis
Current Pharmaceutical Design (2014) Vol. 20, Iss. 13, pp. 2072-2088
Closed Access | Times Cited: 57
2012 Division of Medicinal Chemistry Award Address. Trekking the Cannabinoid Road: A Personal Perspective
Alexandros Makriyannis
Journal of Medicinal Chemistry (2014) Vol. 57, Iss. 10, pp. 3891-3911
Open Access | Times Cited: 56
Is fat taste ready for primetime?
Nicholas V. DiPatrizio
Physiology & Behavior (2014) Vol. 136, pp. 145-154
Open Access | Times Cited: 54
Cannabinoid CB1 Receptors Inhibit Gut-Brain Satiation Signaling in Diet-Induced Obesity
Donovan A. Argueta, Pedro A. Pérez, Alexandros Makriyannis, et al.
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 48
Anti‐obesity efficacy of LH‐21, a cannabinoid CB1 receptor antagonist with poor brain penetration, in diet‐induced obese rats
Mónica Alonso, Antonia Serrano, Margarita Vida, et al.
British Journal of Pharmacology (2011) Vol. 165, Iss. 7, pp. 2274-2291
Open Access | Times Cited: 56
Cannabis and Δ9-tetrahydrocannabinol (THC) for weight loss?
Bernard Le Foll, José Trigo, Keith A. Sharkey, et al.
Medical Hypotheses (2013) Vol. 80, Iss. 5, pp. 564-567
Closed Access | Times Cited: 54
The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives
Maurizio Baldassarre, F.A. Giannone, Lucia Napoli, et al.
Liver International (2013) Vol. 33, Iss. 9, pp. 1298-1308
Closed Access | Times Cited: 52
A thermal window for yawning in humans: Yawning as a brain cooling mechanism
Jorg J. M. Massen, Kim Dusch, Omar Tonsi Eldakar, et al.
Physiology & Behavior (2014) Vol. 130, pp. 145-148
Open Access | Times Cited: 46
Fasting stimulates 2-AG biosynthesis in the small intestine: role of cholinergic pathways
Nicholas V. DiPatrizio, Miki Igarashi, Vidya Narayanaswami, et al.
AJP Regulatory Integrative and Comparative Physiology (2015) Vol. 309, Iss. 8, pp. R805-R813
Open Access | Times Cited: 45
Endocannabinoids in Body Weight Control
Henrike Horn, Béatrice Böhme, L. Dietrich, et al.
Pharmaceuticals (2018) Vol. 11, Iss. 2, pp. 55-55
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top